Venter discusses the future of genomics

03/12/2013 | Medscape (free registration)

The next step in the genomics revolution is to incorporate genomics into drug testing and development, says genomics pioneer J. Craig Venter. As genome sequencing has gotten faster and cheaper, it has also gotten less accurate, and a diploid genome map is necessary to pinpoint the genetics associated with a given disease, Venter said. His new institute on the University of California, San Diego, campus will focus on synthetic and environmental genomics research as well as the relationship between microbiomes and disease.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA